Prosecution Insights
Last updated: May 29, 2026
Application No. 18/575,750

SENSOR UNIT FOR MEASURING BIOMETRIC INFORMATION

Non-Final OA §112
Filed
Dec 29, 2023
Priority
Jun 29, 2021 — RE 10-2021-0084704 +1 more
Examiner
LIU, CHU CHUAN
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
I-Sens Inc.
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
11m
Est. Remaining
85%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allowance Rate
541 granted / 759 resolved
+1.3% vs TC avg
Moderate +14% lift
Without
With
+13.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
36 currently pending
Career history
800
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
65.7%
+25.7% vs TC avg
§102
4.7%
-35.3% vs TC avg
§112
4.1%
-35.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 759 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-9 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims that depend directly or indirectly from claim 1 is/are also rejected due to said dependency. In regard to claim 1, the claim recites “wherein the sensor unit in configured to be attachable to the skin of the user… inclination with respect to the sensor body is changed to be tilted”. First of all, it is unclear whether “the sensor unit in configured to be attachable” comprises any missing limitations between “in” and “configured” (e.g. additional structural element(s)/ configuration(s)) or it is a typo and should be set forth “is”. Secondly, it is unclear what element/ portion/ part the “inclination” refers to. Clarification is requested by amendments. According to Figs. 7-13 of the specification, it appears that “inclination of the insertion portion” with respect to the sensor body is changed. Thus, the limitations are interpreted as “inclination of the insertion portion with respect to the sensor body is changed…” for the purpose of compact prosecution. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Peterson et al. (USPGPUB 2016/0058344) teaches a subcutaneous sensor inserter (Figs. 10-24) comprises a sensor (element 120, Figs. 14-24) includes an insertable portion with sensors (elements 130/132/134, Fig. 20), a needle (element 100, Fig. 11), and a sensor unit configured to be attachable to the skin of the user (Figs. 13-14), wherein the sensor comprises bent portions (Figs. 15-22) and after insertion and removal of needle (Figs. 31-33), the insertable portion is maintained at a location within the lumen (lumen 973, Figs. 24A, 24D and 31-33) but does not specifically teach the inclination of the insertion portion with respect to the sensor body is changed to be tilted with respect to a longitudinal direction central axis of an incision portion created by the needle. Brister et al. (USPGPUB 2008/0242961) teaches a transcutaneous analyte sensor (Figs. 1-4, 7 and 9-12) comprises a sensor (element 32, Figs. 1-4, 7 and 9-12) includes an insertable portion with sensors (element 42, Figs. 4A and 5B-5C) wherein the sensor comprises a bent portion (Figs. 4A, 10A-10B and 11A-11B) and after insertion and removal of a needle (Figs. 7A-7D and 10A-10B), the insertable portion is maintained at a location within the tissue (Figs. 10B and 11B) with greater flexibility ([0142]) but does not specifically teach the inclination of the insertion portion with respect to the sensor body is changed to be tilted with respect to a longitudinal direction central axis of an incision portion created by the needle. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHU CHUAN LIU whose telephone number is (571)270-5507. The examiner can normally be reached M-Th (6am-6pm). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Robertson can be reached at (571) 272-5001. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /CHU CHUAN LIU/Primary Examiner, Art Unit 3791
Read full office action

Prosecution Timeline

Dec 29, 2023
Application Filed
Feb 20, 2026
Non-Final Rejection mailed — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635920
SYSTEMS, DEVICES, AND METHODS FOR PERFORMING TRANS-ABDOMINAL FETAL OXIMETRY AND/OR TRANS-ABDOMINAL FETAL PULSE OXIMETRY USING A FETAL HEARTBEAT SIGNAL FOR A PREGNANT MAMMAL
3y 11m to grant Granted May 26, 2026
Patent 12629067
LIGHT EMITTING DIODE TEMPERATURE ESTIMATION
3y 7m to grant Granted May 19, 2026
Patent 12622645
SIGNAL-EMITTING AND RECEIVING MEDICAL DEVICES WHICH PROVIDE DATA FOR REAL-TIME MULTI-DIMENSIONAL ANATOMIC VISUALIZATION MAPS
3y 11m to grant Granted May 12, 2026
Patent 12616399
COMBINATION OF REFLECTIVE AND TRANSMISSIVE SENSORS WITH CHARACTERISTIC WAVELENGTHS FOR PHYSIOLOGICAL MONITORING
3y 3m to grant Granted May 05, 2026
Patent 12616419
STRUCTURALLY DYNAMIC AND RECONFIGURABLE SMART MEDICAL DEVICES
2y 9m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
85%
With Interview (+13.5%)
3y 4m (~11m remaining)
Median Time to Grant
Low
PTA Risk
Based on 759 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month